The effect of peptidase inhibitors on the release of met5-enk-arg6-phe7 (YGGFMRF) and met5-enkephalin (YGGFM) from spinal cord induced by substance P in vivo
- 31 December 1983
- journal article
- Published by Elsevier in Life Sciences
- Vol. 33, 121-124
- https://doi.org/10.1016/0024-3205(83)90459-9
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Metabolism of enkephalins and the inactivating neuropeptidase conceptTrends in Neurosciences, 1983
- Distribution of Met5-enkephalin-Arg6,Phe7 in rat spinal cordBrain Research, 1983
- Characterization and Location of Met5‐Enkephalin‐Arg6‐Phe7 Stored in Various Rat Brain RegionsJournal of Neurochemistry, 1983
- Substance PJournal of Medicinal Chemistry, 1982
- Studies on the location and release of cholecystokinin and vasoactive intestinal peptide in rat and cat spinal cordBrain Research, 1982
- In vivo and in vitro Effects of Substance P on the Release of β-Endorphin-Like ImmunoreactivityNeuroendocrinology, 1982
- Conversion of [met5] -enkephalin-Arg6-Phe7 to [met5]-enkephalin by dipeptidyl carboxypeptidaseNeuropharmacology, 1981
- Tolerance to electroacupuncture and its cross tolerance to morphineNeuropharmacology, 1981
- Met-enkephalin-Arg6-Phe7 metabolism: Conversion to Met-enkephalin by brain and kidney dipeptidyl carboxypeptidasesBiochemical and Biophysical Research Communications, 1981
- Regional distribution of leu and met enkephalin in rat brainNeuropharmacology, 1977